Acorah Software Products - Accounts Production 15.0.600 false true false true No description of principal activity 9 May 2023 31 May 2024 31 May 2024 14857619 Mr David Clifton iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14857619 2023-05-08 14857619 2024-05-31 14857619 2023-05-09 2024-05-31 14857619 frs-core:CurrentFinancialInstruments 2024-05-31 14857619 frs-bus:PrivateLimitedCompanyLtd 2023-05-09 2024-05-31 14857619 frs-bus:FilletedAccounts 2023-05-09 2024-05-31 14857619 frs-bus:Micro-entities 2023-05-09 2024-05-31 14857619 frs-bus:AuditExempt-NoAccountantsReport 2023-05-09 2024-05-31 14857619 frs-bus:Director1 2023-05-09 2024-05-31
Registered number: 14857619
Connect Life Science Ltd
Unaudited Financial Statements
For the Period 9 May 2023 to 31 May 2024
Balance Sheet
Registered number: 14857619
31 May 2024
£
Fixed assets 3,831
Current assets 36,977
Prepayments and accrued income 12,620
Creditors: Amounts Falling Due Within One Year (29,631 )
NET CURRENT ASSETS 19,966
TOTAL ASSETS LESS CURRENT LIABILITIES 23,797
Accruals and deferred income (8,958 )
NET ASSETS 14,839
CAPITAL AND RESERVES 14,839

Notes

1. General Information
Connect Life Science Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 14857619 . The registered office is 27 Old Gloucester Street, London, WC1N 3AX.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 2
2
For the period ending 31 May 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Mr David Clifton
Director
17/09/2024